-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on AbbVie, Raises Price Target to $303

Benzinga·08/20/2026 16:15:14
Listen to the news
Piper Sandler analyst David Amsellem maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $298 to $303.